4-(2-succinimidyloxycarbonylethyl)phenyl-10-methylacridinium-9-carboxylate has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cook, RW; Gale, RE; Harvey, RC; Langabeer, SE; Linch, DC; Mackinnon, S | 1 |
1 other study(ies) available for 4-(2-succinimidyloxycarbonylethyl)phenyl-10-methylacridinium-9-carboxylate and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia.
Topics: Acridines; Bone Marrow Transplantation; DNA Probes; Fusion Proteins, bcr-abl; Gene Amplification; Graft Enhancement, Immunologic; Humans; Hybridization, Genetic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luminescent Measurements; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Risk Factors; RNA, Messenger; RNA, Neoplasm; Succinimides; Transcription, Genetic | 2002 |